Veeva Commercial Summit: Increased investment in medical affairs by pharma companies
Veeva’s VP of global medical, Christoph Bug, emphasises the importance of scientific exchange between clinical experts and pharmaceutical companies.
Veeva’s VP of global medical, Christoph Bug, emphasises the importance of scientific exchange between clinical experts and pharmaceutical companies.
The consortium aims to attract global pharma and medical device companies for clinical trial research investment in Israel.
The pharmaceutical industry continues to be a hotbed of innovation, with activity driven by the evolution of new treatment paradigms,...
Pharma Technology Focus is our digital magazine, free to read online on all devices. Click the magazine cover to read the latest issue. You can subscribe for free to have each new issue delivered to your inbox.
J&J MedTech wins IDE for Ottava to greenlight trials for surgical robot
Trump 2.0 spells uncertainty for US healthcare, says analyst
Ethics and regulation come into focus in the age of AI-powered clinical trials
Reeves’ 2024 budget promises life sciences investment